drugset
drugset / Trial / NCT00809068

High-density Lipoprotein (HDL) Cholesterol in Women Taking Tibolone

NCT00809068 ↗

Phase 4 Completed 20 enrolled Keogh Institute for Medical Research
RandomizedCrossoverSingle-blindPrevention

Summary

Tibolone (Livial) has been shown in previous studies to lower HDL cholesterol by up to 40%. This study aims to study the effects of fenofibrate on HDL and subfractions in women taking tibolone.

Timeline

Start
2005-08
Primary completion
2009-08
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fenofibrate Small molecule 160 mg —
Comparator Tibolone Other / unclassified 2.5 mg —

Indications

No indication recorded.